Conference Day Two

8.00 Registration & Morning Coffee

8.50 Chair’s Opening Remarks & Start of Day Two

Understanding the Data Required to Substantiate Claims & Appeal to Regulators

9.00 Product Ideation to Validation – Planning Effective Clinical Trials for Saftey & Substantiation

Synopsis

  • Key considerations for preclinical in-vitro, ex-vivo and other screening proof of concept means to demonstrate functional ingredient efficacy
  • Collecting necessary clinical and consumer data for substantiation and towards expanding any Intellectual Property towards patents
  • Incorporating scientific, marketing, and patent law insights into the development of novel products

9.30 Making the Most of the Clinic: Designing Studies Robustly to Ensure Safety, Obtain GRAS Status, & Generate High-Quality Data Sets for Use in Efficacy Claims

Synopsis

  • Assessing the data necessary to demonstrate product safety, support NDI approval, and obtain GRAS status
  • Developing clinical design strategies to provide data and insights into product efficacy, justifying further investment, research, and claims
  • Utilizing clinical data to educate consumers on the science behind validated claims and establish your product’s legitimacy

10.00 Maximizing Clinical & Consumer Data for Efficacy Claims into Gut Health Support Through Prebiotics

Synopsis

  • Exploring systems for substantiating prebiotic claims and the data required to prove effective microbiome promotion
  • Discussing the data that should be gathered from models, clinical studies, and consumers to effectively demonstrate efficacy and elucidate the mechanisms by which the benefit is achieved
  • Deep dive into why and how certain prebiotics lead to measurable health benefits in consumers

10.30 Structured Networking Break

Leveraging Consumer Insights to Meet Functional Product Market Demand

11.00 Consumer Perceptions of Genetically Engineered Bacteria for Probiotic Products & Regulatory Considerations as We Build a New Category

Synopsis

  • Why genetically engineered probiotics are the inevitable future of the probiotics industry
  • Delving into the actual consumer response to GM bacteria for use in probiotics after 5+ years on the market
  • Navigating the potential challenges and regulatory grey areas related to introducing novel biotechnologies to the market, and proposed go-forward solutions

11.30 Understanding Consumer Reaction to the Diversification of Microbiome Modalities & Products

  • Len Monheit Executive Director, Global Prebiotic Association

Synopsis

  • What does the consumer think of the differences between pro, pre, post, syn, and more biotics terms?
  • Deepening understanding of microbiome testing solutions and personalized microbiome products
  • How have consumer opinions changed regarding microbiome-targeting products over the last decade?

12.00 Lunch & Networking Break

Establishing Robust & Efficient Product Pipelines

1.00 Assessing Scale-Up & Market Launch of Functional Vegan Milk Alternatives

Synopsis

  • Comparing the benefits of contemporary milk ingredient production methods, including fermentation, plant extraction, and cell culture for production
  • Exploring the challenges in producing functional milk ingredients by sustainable, scalable, and cost effective methods
  • Discussing market launch strategies and which consumer segments are most likely to engage with alternative milk products

1.30 Improving the Lab-Bench to Store-Shelf Pipeline to Overcome Challenges in the Application & Scaleup of Novel Ingredients

  • Vien-An Friedel Director - Global Formulation Governance, TurtleTree Labs

Synopsis

  • Addressing the practical issues of integrating and formulating products into beverages while maintaining functionality, stability, and consumer appeal
  • Navigating regulatory and logistical challenges of market transition to bring high-quality functional products from bench to shelf efficiently

2.00 Development of SBD111 as a Medical Food for the Dietary Management of Postmenopausal Bone Loss

Synopsis

  • Clinical study design and data discussion into microbiome based products for bonehealth and skeletal benefits
  • Discussing branding and commercialization strategies for medical food products in the contemporary direct-to-consumer (DTC) microbiome market
  • Targeting and marketing the complex benefits of precision products to consumers in a claim-compliant and effective manner

2.30 Overcoming Challenges in Finding Sustainable Alternatives for Natural Bioactive Products, Upcycling Ingredient By-Products, & Greenifying Supply Chains

Synopsis

  • Identifying what sources of bioactive ingredients are sustainable and comparing various sustainability methods
  • Capitalizing on vertically integrated supply chains to attempt to find upcycling or other uses for ingredient by-products to ensure your product meets increasing consumer demand for eco-friendly products
  • What are the current technical challenges in producing functional ingredient products in more sustainable ways?

3.00 Structured Networking Break

3.45 Panel Discussion: Integrating Nutrition Insights into R&D, Affairs & Marketing to Ensure Collaboration & Optimize Product Nutritional Value

  • Junrui Cheng Sr Nutrition Scientist, ingredion
  • Ariel Beverly Design Team Leader, Nutritional Beverages, International Flavors & Fragrances

Synopsis

  • How does nutrition for functional food & beverages differ from ‘standard’ products
  • How can you enable cross-functional collaboration at all stages in product development to achieve product goal alignment & have optimal product launches
  • What aspects of product pipelines are most likely to lead to nutrition concerns and how can they be mitigated in early R&D?

4.30 Chair’s Closing Remarks & End of the Bioactive Formulation for Functional F&B Summit